Paid search for digital health must navigate Google's restricted health content policies, HIPAA limits on remarketing and audience targeting, and a buying cycle that frequently involves a clinician or benefits stakeholder instead of one self-serve buyer. Winston Francois develops paid search programs for digital health companies that win approval, remain approved, and are measured against actual pipeline rather than disapproved-and-reapproved click volume.
The Challenge
Google's personalized health conditions and health content policies reject ads that a typical SaaS team would never anticipate triggering
Ads and landing pages that reference specific health conditions, use before/after framing, or target based on inferred health status can get disapproved outright or restricted to policy-compliant ad formats, and the rules differ by condition category and by country. Teams that write ad copy the way they would for any other B2B or DTC product routinely get campaigns paused mid-flight, losing weeks of ramp time while they figure out which line triggered the policy and refile.
HIPAA restrictions rule out conventional remarketing and audience-building methods
Retargeting users who visited a page about a specific condition, or building lookalike audiences off a list of people who engaged with a symptom-specific landing page, can create HIPAA exposure because that activity implies knowledge of someone's health status shared with an ad platform. Digital health teams that copy remarketing playbooks from other categories either build audiences they should not be building or, more often, avoid remarketing entirely and leave real efficiency on the table because nobody set up a compliant alternative.
The real buyer is frequently a clinician, benefits leader, or payer contact rather than the searcher who clicks the ad
A consumer might search for a symptom or condition, but for B2B2C and enterprise digital health products, the person who ultimately signs off is an employer benefits leader, a health system procurement contact, or a payer medical director evaluating the product on entirely different criteria than the searcher. Campaigns built purely around consumer symptom-search intent generate consumer volume that has no bearing on the enterprise deals actually driving revenue.
Landing pages designed for conversion volume fall short for buyers seeking clinical credibility
A generic SaaS landing page pattern – hero claim, testimonial logos, a form – does not answer the questions a clinical or procurement stakeholder actually has: what is the evidence base, is this FDA-cleared or exempt, how does data handling work, what does integration with existing EHR workflows look like. Pages optimized only for form-fill rate can put up decent top-line numbers while converting almost none of the stakeholders who actually move a deal forward.
How We Can Help
We begin by auditing your account and campaign structure against Google's actual health-content policies for your particular condition categories and geographies, because the rules vary and guessing is what leads to mid-campaign disapprovals.
Next, we develop keyword strategy around genuine buyer intent for your specific model – consumer symptom and condition searches when you are DTC, and job-title-plus-problem searches for benefits leaders, procurement contacts, or clinical decision-makers when selling to employers, payers, or health systems.
We shape remarketing and audience strategy around what HIPAA genuinely permits – contextual and non-health-status-based targeting, compliant use of first-party data where consent allows it, and clear records of what we are and are not doing with visitor data, reviewed with your compliance or legal team before launch rather than following a complaint.
Landing pages are created for the buyer who ultimately has to approve the purchase: directly addressing clinical evidence, regulatory status, and data handling for stakeholders assessing credibility, while providing a separate, simpler conversion path for consumers who only need a clear next step.
Measurement connects to your CRM and, when relevant, your enterprise sales pipeline rather than ending with ad-platform conversion events, because a benefits leader or health system contact converting through paid search can take months to close, and last-click attribution will make the channel appear dead well before it delivers a return.
The fractional, embedded approach is especially important here because paid search policy and HIPAA restrictions alter the tactical playbook enough that a generalist PPC agency using standard tactics will encounter disapprovals and compliance risks it lacks the context to anticipate.
What we deliver
- Keyword and campaign strategy segmented for consumer intent vs. enterprise buyer intent
- Ad copy and landing pages reviewed against Google's health content and personalized health conditions policies
- HIPAA-compliant remarketing and audience strategy documented for legal sign-off
- CRM-connected attribution tracking pipeline instead of only ad-platform conversions
The paid search teams succeeding in digital health are not those writing the strongest ad copy—they are the teams that avoid disapproval from the outset because they understood the policy before launching.
Our Methodology
We operate digital health paid search through a 90-day build-and-optimize cycle because policy review, compliant audience configuration, and attribution instrumentation all require meaningful time before campaign spend should scale. Phase one (weeks 1-3) focuses on policy and intent research – mapping your particular condition categories to Google's restricted health content rules, dividing the keyword universe by consumer versus enterprise buyer intent, and reviewing remarketing plans against HIPAA restrictions with your compliance stakeholder before anything gets built.
Phase two (weeks 4-8) covers campaign development and a controlled launch – creating distinct campaign structures and landing pages for consumer and enterprise intent, launching under budget caps while confirming ads pass policy review and remain approved, and connecting attribution to your CRM so pipeline data flows from day one rather than being added afterward.
Phase three (weeks 9-12) centers on optimization using real signals – shifting budget toward keyword segments and landing pages that generate qualified pipeline rather than clicks alone, and expanding into adjacent compliant keyword territory found during phase one but reserved until the first campaigns demonstrated stability.
What separates this operator approach from a typical PPC engagement is that policy and compliance review is a planned phase-one workstream, rather than an emergency after your third disapproval notice.
Our Working Approach
Engagements start with a 30-day audit and policy review in which we assess your existing account structure (or create one from the ground up), evaluate keywords and ad copy against Google's health content policies, and review remarketing plans with your compliance stakeholder – this phase by itself identifies most disapproval risk before it costs campaign time. By day 60, you should have live, policy-approved campaigns separated by buyer type, with attribution data flowing into your CRM.
By day 90, you should have sufficient performance data to identify which keyword segments and landing pages drive actual pipeline rather than conversions alone, plus a clear plan for the next budget shifts. We work as an embedded team with weekly optimization check-ins, not through a monthly report delivered to your inbox.
Your team must provide CRM access so we can link ad spend to real pipeline and revenue, along with access to the person responsible for compliance or legal approval of remarketing and audience strategy – both distinguish a program that passes policy review from one shut down midway through the quarter. Minimum ad spend varies based on keyword competition and buyer segmentation, but meaningful tests across consumer and enterprise intent typically require at least $10K-$20K per month.
Following the first 90 days, we carry on as an ongoing monthly program because policy rules and platform enforcement within the health category shift more frequently than in most B2B verticals, requiring campaigns to be actively monitored rather than set and forgotten.
- Fewer campaign disapprovals and less lost ramp time from policy-compliant setup
- Higher-quality pipeline from buyer-segmented keyword and landing page strategy
- Documented HIPAA-compliant remarketing approach that clears legal review
- Pipeline-connected attribution replacing last-click ad-platform reporting
If your digital health company needs paid search (sem) leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What is the cost of a paid search program for a digital health company?
Management fees generally range from $4K-$8K per month based on the number of buyer segments and campaign structures involved, in addition to ad spend that meaningfully begins at roughly $10K-$20K monthly when testing both consumer and enterprise buyer intent. Businesses selling exclusively DTC within one condition category can usually begin smaller; those operating parallel consumer and enterprise campaigns need the higher range to produce dependable data across both.
How do you navigate Google's restricted health content policies?
Before writing even one ad, we assess your exact condition categories and geographies against the current policy set, determining whether standard campaigns are feasible, a restricted-format workaround is required, or a keyword area should be excluded from paid search altogether. This review takes place in phase one, so policy conflicts are not discovered through post-launch disapproval notices.
Can a digital health company remarket under HIPAA at all?
Yes, though not through the approach most teams use by default – retargeting tied to condition-specific page visits or inferred health status introduces real exposure, so we instead develop audience strategy around contextual and consent-based methods, documented and reviewed with your compliance team before launch. The playbook is narrower than standard e-commerce remarketing, but it is not nonexistent.
What makes this different from a typical performance marketing agency?
A general agency typically applies the same keyword and remarketing playbook used for every other client, running into health-category policy barriers and HIPAA exposure it did not anticipate. We begin with the actual restrictions governing this category and design campaign structure around them from day one, using people who have already developed compliant health-category programs instead of learning the rules through your account.
How do you calculate ROI when an enterprise buying cycle lasts months?
We link ad spend with your CRM and measure pipeline influence and assisted conversions rather than depending on last-click conversions reported by ad platforms, because a benefits leader or health system contact who initially converts through paid search might not close for months, making that spend appear wasted in last-click data. Proper setup requires CRM access from your team.
Which type of digital health company is the right fit for this?
Companies with monthly ad budgets of at least $10K that either sell DTC in regulated health-condition categories or operate combined consumer-and-enterprise buyer motions targeting health systems, payers, or employers. If your existing paid search program handles every visitor identically, whether they are a consumer or benefits leader, that is generally the strongest indication that it requires rebuilding.
